TABLETS · MEDROOTS BIOPHARMA

SYLPRED-4

INR 610
Learn more
In stock

Description

SYLPRED-4

Methylprednisolone Tablets IP 4 mg

Marketed by Medroots Biopharma – A Trusted PCD Pharma Company

Effective Anti-Inflammatory & Immunosuppressive Therapy

SYLPRED-4 contains Methylprednisolone 4 mg, a corticosteroid indicated for the management of inflammatory, allergic, autoimmune, and certain respiratory conditions. It helps reduce inflammation, swelling, redness, and immune system overactivity, providing effective symptom relief when used under medical supervision.

Composition

Each tablet contains:

Methylprednisolone IP 4 mg

Excipients: q.s.

Key Benefits

Helps reduce inflammation and swelling

Provides effective relief in allergic conditions

Supports the management of autoimmune disorders

Useful in rheumatic and musculoskeletal disorders

Assists in controlling asthma exacerbations and other inflammatory respiratory conditions

Delivers consistent therapeutic efficacy with quality manufacturing standards

Common Clinical Uses

Severe allergic reactions

Bronchial asthma (as prescribed)

Rheumatoid arthritis

Autoimmune disorders

Dermatological inflammatory conditions

Eye inflammation

Certain endocrine and respiratory disorders

Directions for Use

Take SYLPRED-4 exactly as prescribed by a qualified healthcare professional. The dosage and duration depend on the patient's condition and clinical response. Do not discontinue corticosteroid therapy abruptly unless advised by a physician.

Storage

Store in a cool, dry place below 25°C.

Protect from moisture and direct sunlight.

Keep out of reach of children.

Why Choose Medroots Biopharma?

Quality-focused pharmaceutical products

Wide portfolio of ethical medicines

Attractive PCD Pharma franchise opportunities

Monopoly rights in selected territories

Comprehensive promotional support

Reliable supply chain and customer service

SYLPRED-4 – Trusted Corticosteroid Therapy for Effective Inflammation Management

Marketed by Medroots Biopharma

Delivering Quality • Innovation • Affordable Healthcare